These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6605449)

  • 1. Heterogeneity of T-cell neoplasias as defined by monoclonal antibodies.
    Herrmann F; Komischke B; Sieber G; Rühl H
    Klin Wochenschr; 1983 Aug; 61(16):807-12. PubMed ID: 6605449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic diversity of T cell leukemias.
    Greaves MF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):75S-80S. PubMed ID: 6982279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.
    Pandolfi F; Semenzato G; de Rossi G; Quinti I; Guglielmi C; Pezzutto A; Lopez M; Tonietti G; Fontana L; Abo T; Aiuti F
    Clin Exp Immunol; 1983 Jun; 52(3):641-7. PubMed ID: 6603302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.
    Knowles DM; Halper JP
    Am J Pathol; 1982 Feb; 106(2):187-203. PubMed ID: 6978074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunodiagnosis of chronic lymphatic leukemia and leukemic non-Hodgkin's lymphoma with the monoclonal antibodies BL-Ig-L/1, BL-DR/1 and BL-T2].
    Malberg K; Fischer H; Elendt D; Wutke K; Fiebig H
    Arch Geschwulstforsch; 1984; 54(4):325-32. PubMed ID: 6437368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopathology of lymphatic systemic diseases].
    Huber H; Gattringer C
    Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing human malignant T cells with lectins: a comparison with their surface antigen patterns defined by monoclonal antibodies.
    Richard Y; Boumsell L; Lemerle J; Valensi F; Bernard A
    Leuk Res; 1982; 6(3):307-12. PubMed ID: 6981736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity and cellular origins of T cell malignancies.
    Greaves MF; Rao J; Hariri G; Verbi W; Catovsky D; Kung P; Goldstein G
    Leuk Res; 1981; 5(4-5):281-99. PubMed ID: 6974808
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies recognizing T-cells (Leu 1) and transferrin receptor (OKT 9) crossreact with malignant B-cells of distinct differentiation stages.
    Ludwig WD; Kolecki P; Sieber G; Herrmann F
    Tumour Biol; 1984; 5(6):321-6. PubMed ID: 6100222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of currently available monoclonal antibodies with conventional markers for phenotyping of one hundred acute leukemias.
    Thiel E; Kummer U; Rodt H; Stünkel K; Munker R; Majdic O; Knapp W; Thierfelder S
    Blut; 1982 Feb; 44(2):95-100. PubMed ID: 6977392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological classification of T-cell acute lymphoblastic leukaemia using monoclonal antibodies.
    Chen PM; Chiang H; Chou CK; Hwang TS; Chiang BN; Greaves MF
    Leuk Res; 1983; 7(3):339-48. PubMed ID: 6350729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.